Prospective, Randomized Phase III Trial of I.V. Vinflunine Plus Best Supportive Care as Second Line Therapy Versus Best Supportive Care After a Platinum-Containing Regimen, in Patients With Advanced Transitional Cell Carcinoma of Urothelial Tract.
Phase of Trial: Phase III
Latest Information Update: 17 Feb 2013
At a glance
- Drugs Vinflunine (Primary)
- Indications Bladder cancer; Urogenital cancer
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 16 Apr 2010 Updated survival results presented at the 25th Annual Congress of the European Association of Urology.
- 12 Jan 2010 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
- 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History